Pfizer digs into data: can its vaccine stop long COVID?
NCT ID NCT05876377
Summary
This study uses existing health insurance and state vaccination records to answer two main questions. First, it aims to measure how well the Pfizer-BioNTech COVID-19 vaccine prevents Long COVID symptoms. Second, it seeks to understand the characteristics of people who are getting the updated vaccines. The research analyzes data from thousands of patients in California and Louisiana without directly treating anyone.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COVID-19 are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Pfizer
New York, New York, 10001, United States
Conditions
Explore the condition pages connected to this study.